198 related articles for article (PubMed ID: 8756659)
21. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
Agostini I; Navarro JM; Rey F; Bouhamdan M; Spire B; Vigne R; Sire J
J Mol Biol; 1996 Sep; 261(5):599-606. PubMed ID: 8800208
[TBL] [Abstract][Full Text] [Related]
22. A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins.
Braselmann S; Graninger P; Busslinger M
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1657-61. PubMed ID: 8446579
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides.
Wu TJ; Monokian G; Mark DF; Wobbe CR
Mol Cell Biol; 1994 May; 14(5):3484-93. PubMed ID: 8164693
[TBL] [Abstract][Full Text] [Related]
24. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
[TBL] [Abstract][Full Text] [Related]
25. B-MYB transactivates its own promoter through SP1-binding sites.
Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
[TBL] [Abstract][Full Text] [Related]
26. Chimeric liver transcription factors LFB1 (HNF1) containing the acidic activation domain of VP16 act as positive dominant interfering mutants.
Denecke B; Bartkowski S; Senkel S; Klein-Hitpass L; Ryffel GU
J Biol Chem; 1993 Aug; 268(24):18076-82. PubMed ID: 8394359
[TBL] [Abstract][Full Text] [Related]
27. The bovine herpesvirus alpha gene trans-inducing factor activates transcription by mechanisms different from those of its herpes simplex virus type 1 counterpart VP16.
Misra V; Walker S; Hayes S; O'Hare P
J Virol; 1995 Sep; 69(9):5209-16. PubMed ID: 7636962
[TBL] [Abstract][Full Text] [Related]
28. The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPc.
Mittal V; Cleary MA; Herr W; Hernandez N
Mol Cell Biol; 1996 May; 16(5):1955-65. PubMed ID: 8628262
[TBL] [Abstract][Full Text] [Related]
29. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
Ghosh S; Selby MJ; Peterlin BM
J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
[TBL] [Abstract][Full Text] [Related]
30. Functional domains of the heavy metal-responsive transcription regulator MTF-1.
Radtke F; Georgiev O; Müller HP; Brugnera E; Schaffner W
Nucleic Acids Res; 1995 Jun; 23(12):2277-86. PubMed ID: 7610056
[TBL] [Abstract][Full Text] [Related]
31. Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y.
Leger H; Sock E; Renner K; Grummt F; Wegner M
Mol Cell Biol; 1995 Jul; 15(7):3738-47. PubMed ID: 7791781
[TBL] [Abstract][Full Text] [Related]
32. Redundancy of class III POU proteins in the oligodendrocyte lineage.
Schreiber J; Enderich J; Sock E; Schmidt C; Richter-Landsberg C; Wegner M
J Biol Chem; 1997 Dec; 272(51):32286-93. PubMed ID: 9405434
[TBL] [Abstract][Full Text] [Related]
33. Protease footprinting reveals a surface on transcription factor TFIIB that serves as an interface for activators and coactivators.
Hori R; Pyo S; Carey M
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6047-51. PubMed ID: 7597078
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional analysis of acetylcholine receptor alpha 3 gene promoter motifs that bind Sp1 and AP2.
Yang X; Fyodorov D; Deneris ES
J Biol Chem; 1995 Apr; 270(15):8514-20. PubMed ID: 7721749
[TBL] [Abstract][Full Text] [Related]
35. c-Jun transactivates the promoter of the human p21(WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1.
Kardassis D; Papakosta P; Pardali K; Moustakas A
J Biol Chem; 1999 Oct; 274(41):29572-81. PubMed ID: 10506225
[TBL] [Abstract][Full Text] [Related]
36. Structural flexibility in transcription complex formation revealed by protein-DNA photocrosslinking.
Cleary MA; Pendergrast PS; Herr W
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8450-5. PubMed ID: 9237997
[TBL] [Abstract][Full Text] [Related]
37. Positive and negative regulation at the herpes simplex virus ICP4 and ICP0 TAATGARAT motifs.
Douville P; Hagmann M; Georgiev O; Schaffner W
Virology; 1995 Feb; 207(1):107-16. PubMed ID: 7871718
[TBL] [Abstract][Full Text] [Related]
38. Biochemical characterization of the Oct-2 POU domain with implications for bipartite DNA recognition.
Botfield MC; Jancso A; Weiss MA
Biochemistry; 1992 Jun; 31(25):5841-8. PubMed ID: 1610826
[TBL] [Abstract][Full Text] [Related]
39. The POU domain transcription factors Oct-6 and Oct-11 negatively regulate loricrin gene expression in keratinocytes: association with AP-1 and Sp1/Sp3.
Kawachi Y; Ishitsuka Y; Maruyama H; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Ichikawa E; Otsuka F
Arch Dermatol Res; 2013 Jul; 305(5):371-8. PubMed ID: 23341029
[TBL] [Abstract][Full Text] [Related]
40. Conformational alteration of Oct-1 upon DNA binding dictates selectivity in differential interactions with related transcriptional coactivators.
Misra V; Walter S; Yang P; Hayes S; O'Hare P
Mol Cell Biol; 1996 Aug; 16(8):4404-13. PubMed ID: 8754841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
